title: Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
abstract: An increased free-radical production has been documented during hemodialysis (HD) particularly when bio-incompatible membranes are utilized. These highly reactive free radicals can cause damage through several pathways, one of the best known being lipid peroxidation. Malondialdehyde (MDA) is a product of lipid peroxidation, which can partly be removed by HD due to its low molecular weight and water solubility. Hydroperoxides are predominantly found in lipid substances, and therefore their removal by HD could be difficult. We evaluated the behavior of these two by-products of lipid peroxidation during HD, comparing their behavior in three different membranes, in order to study their reliability as markers of acute oxidative injury. Fifteen stable HD patients were dialyzed with each of the following membranes: cuprophan, polyamide, and polysulfone, three sessions for every membrane. MDA and hydroperoxides were measured pre-HD and then both from the arterial and venous line at 8, 15, 30, and 240 min. During HD with cuprophan membrane MDA decreased significantly in the venous line compared with the arterial line at 8, 15, and 30 min (P < 0.05). At the end of HD, MDA was significantly reduced compared with MDA pre-HD (P < 0.05). Plasma hydroperoxides increased significantly in the venous line compared with the arterial line at 8, 15, 30, and 240 min (P < 0.05). At the end of HD, hydroperoxides had increased significantly as compared with pre-HD (P < 0.05). When the polyamide and polysulfone membranes were used, the behavior of MDA was similar to that found with cuprophan. Hydroperoxides were unchanged during HD using both membranes. MDA is not a reliable marker of acute oxidative injury during HD as it is removed during HD. Hydroperoxide measurement is a better marker of acute oxidative injury during HD.
authors.affiliation: Division of Nephrology, University Hospital, Modena, Italy. lucchi.leonardo@policlinico.mo.it
authors.forename: Leonardo
authors.initials: L
authors.lastname: Lucchi
authors.forename: Anna
authors.initials: A
authors.lastname: Iannone
authors.forename: Stefania
authors.initials: S
authors.lastname: Bergamini
authors.forename: Lucia
authors.initials: L
authors.lastname: Stipo
authors.forename: Salvatore
authors.initials: S
authors.lastname: Perrone
authors.forename: Simona
authors.initials: S
authors.lastname: Uggeri
authors.forename: Valentina
authors.initials: V
authors.lastname: Gatti
authors.forename: Federica
authors.initials: F
authors.lastname: Ferrari
authors.forename: Aldo
authors.initials: A
authors.lastname: Tomasi
authors.forename: Alberto
authors.initials: A
authors.lastname: Albertazzi
mesh_terms: D000368:Aged; D001672:Biocompatible Materials; D015415:Biomarkers / Q000097:blood; D002482:Cellulose / Q000031:analogs & derivatives; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008054:Lipid Peroxides / Q000097:blood*; D008297:Male; D008315:Malondialdehyde / Q000097:blood*; D008567:Membranes, Artificial; D009757:Nylons; D018384:Oxidative Stress; D011108:Polymers; D006435:Renal Dialysis / Q000009:adverse effects*; D013450:Sulfones
chemical_list: D001672:Biocompatible Materials; D015415:Biomarkers; D008054:Lipid Peroxides; D008567:Membranes, Artificial; D009757:Nylons; D011108:Polymers; D013450:Sulfones; C017662:polysulfone P 1700; D008315:Malondialdehyde; D002482:Cellulose; C009865:cuprammonium cellulose